v3.26.3
Basic and Diluted Net Income Per Share
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Basic and Diluted Net Income Per Share Basic and Diluted Net Income Per Share
Basic earnings per share of Class A and Class B common stock is computed by dividing net income attributable to Guardian Pharmacy Services, Inc. by the weighted-average number of shares of Class A and Class B common stock outstanding during the period. The Class A and Class B common stock are identical in their rights and privileges, except that shares of Class B common stock are subject to transfer restrictions prior to their conversion into shares of Class A common stock. Therefore, the basic earnings per share for Class A and Class B common stock will be equal. Diluted earnings per share of Class A and Class B common stock is computed by dividing net income attributable to Guardian Pharmacy Services, Inc. by the weighted-average number of shares of Class A and Class B common stock outstanding, adjusted to give effect to potentially dilutive elements.
The following table sets forth the computation of net income attributable to the Company used to compute basic net income per share of Class A and Class B common stock for the three and nine months ended September 30, 2025 and 2026.
(in thousands)Three Months Ended
September 30, 2025
Three Months Ended
September 30, 2026
Nine Months Ended
September 30, 2025
Nine Months Ended
September 30, 2026
Numerator:
Net income$9,593 $19,120 $27,693 $54,785 
Less net income (loss) attributable to non-controlling interests(225)440 (603)938 
Net income attributable to Guardian Pharmacy Services, Inc.$9,818 $18,680 $28,296 $53,847 
The following table sets forth the computation of basic and diluted net income per share of Class A and Class B common stock (in thousands, except per share amounts):
Three Months Ended
September 30, 2026
Nine Months Ended
September 30, 2026
Class AClass BClass AClass B
Basic net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.$14,815 $3,865 $38,836 $15,011 
Denominator:
Weighted average number of shares of Class A and Class B common stock outstanding50,238 13,105 45,676 17,654 
Basic net income per share attributable to common stockholders$0.29 $0.29 $0.85 $0.85 
Diluted net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.$14,815 $3,865 $38,836 $15,011 
Denominator:
Number of shares used in basic computation50,238 13,105 45,676 17,654 
Dilutive Restricted Stock Units and Class A and B Common Stock454 119 348 135 
Weighted average shares of Class A and Class B common stock outstanding used to calculate diluted net income per share50,692 13,224 46,024 17,789 
Diluted net income per share attributable to common stockholders$0.29 $0.29 $0.84 $0.84 

Three Months Ended
September 30, 2025
Nine Months Ended
September 30, 2025
Class AClass BClass AClass B
Basic net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.$3,638 $6,180 $8,413 $19,883 
Denominator:
Weighted average number of shares of Class A and Class B common stock outstanding23,021 39,103 18,455 43,616 
Basic net income per share attributable to common stockholders$0.16 $0.16 $0.46 $0.46 
Diluted net income per share attributable to common stockholders
Numerator:
Allocation of net income attributable to Guardian Pharmacy Services, Inc.$3,638 $6,180 $8,413 $19,883 
Denominator:
Number of shares used in basic computation23,021 39,103 18,455 43,616 
Dilutive Restricted Stock Units and Class A and B Common Stock485 824 330 779 
Weighted average shares of Class A and Class B common stock outstanding used to calculate diluted net income per share23,506 39,926 18,785 44,395 
Diluted net income per share attributable to common stockholders$0.15 $0.15 $0.45 $0.45 
There were no material anti-dilutive common share equivalents that were excluded in the computation of diluted net income per share during the three and nine months ended September 30, 2025 and 2026.